Gabexate for the Prevention of Pancreatic Damage Related to Endoscopic Retrograde Cholangiopancreatography

Authors:
  • ATAlberto Tittobello
    Alberto Tittobello
  • AMAlberto Mariani
    Alberto Mariani
  • VFVincenzo Di Francesco
    Vincenzo Di Francesco
  • TGthe Gabexate in Digestive Endoscopy — Italian Group
    the Gabexate in Digestive Endoscopy — Italian Group

Abstract
Endoscopic retrograde cholangiopancreatography (ERCP) is associated with elevated levels of pancreatic enzymes and pancreatitis. Gabexate, a protease inhibitor, has been used to prevent pancreatic damage related to ERCP.

This publication has 22 references indexed in Scilit: